The FDA has approved palbociclib (Ibrance) in combination with trastuzumab (Herceptin), endocrine therapy, and optionally ...

Despite fears of an innovation slowdown, stoked by funding cuts and FDA personnel shakeups, the agency approved 17 ...

Her story is one of a growing number of Australians, New Zealanders, Europeans, and Americans who are travelling to China for ...

The best secrets in Massachusetts aren’t locked in vaults or hidden in mysterious locations. Sometimes they’re just sitting ...

Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most challenging cancers to treat ...

Autologous γδ T cells were lentivirally transduced to express MGMT, enabling persistence during temozolomide and allowing intracavitary delivery via Rickham catheter during maintenance cycles. A ...

UAB researchers report Phase 1 trial results showing a novel immunotherapy safely doubled the time glioblastoma patients ...

For patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL), adding pirtobrutinib to venetoclax-rituximab ...

Results of the ongoing eNRGy trial, a single-arm, multicenter, global phase 2 clinical trial evaluating zenocutuzumab in solid tumors positive for Neuregulin 1 (NRG1) gene fusions, reported manageable ...

Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.

GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. The First Descendant launched today for PC, PlayStation, and Xbox.